Abstract
HIV/AIDS is a global pandemic. The annual number of new HIV infections has steadily declined and due to the significant increase in people receiving antiretroviral therapy, the number of AIDS-related deaths has also declined. Namibia is one of the worst affected countries by HIV/AIDS in the world. Kaposi sarcoma is an opportunistic malignancy that occurs in HIV positive patients, the epidemic of AIDS-related type. Even though Kaposi sarcoma incidence has declined during the late 1990s with the advent of highly active antiretroviral therapy (HAART) against HIV, Namibia must invest more in the screening and treatment of this condition.
Highlights
Introduction and BackgroundHuman immunodeficiency virus (HIV) is an incurable and very potent virus that lowers the immunity and allows for a variety of diseases to flourish in the body
According to the latest world HIV/acquired immune deficiency syndrome (AIDS) rankings, 2009, Namibia falls in the 7th position
In its population of about 2 million, at least 200 000 people are living with HIV/AIDS (UNAIDS, 2010) [6,7,8,9,10,11]
Summary
Human immunodeficiency virus (HIV) is an incurable and very potent virus that lowers the immunity and allows for a variety of diseases to flourish in the body. This state of severe immunosuppression and attack by the opportunistic infections is a stage of the viral infection known as AIDS (acquired immunodeficiency syndrome) [1,2,3]. The annual number of new HIV infections has steadily declined and due to the significant increase in people receiving antiretroviral therapy, the number of AIDS-related deaths has declined. With around 68 percent of all people living with HIV residing in sub-Saharan Africa, the region carries the greatest burden of the epidemic
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Biomedical Science & Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
